Φορτώνει......
Heat shock factor 1 confers resistance to lapatinib in ERBB2-positive breast cancer cells
Despite success of ERBB2-targeted therapies such as lapatinib, resistance remains a major clinical concern. Multiple compensatory receptor tyrosine kinase (RTK) pathways are known to contribute to lapatinib resistance. The heterogeneity of these adaptive responses is a significant hurdle for finding...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cell Death Dis |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Nature Publishing Group UK
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5967334/ https://ncbi.nlm.nih.gov/pubmed/29799521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-018-0691-x |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|